Towards Healthcare
Clinical Trial Services Market Leads USD 141.85 Bn by 2034

Clinical Trial Services Market 2025 Oncology Leads with 39% Share, Rare & Orphan Diseases Fastest Growing Segment

Based on market forecasts, the global clinical trial services market, projected at USD 60.7 billion in 2024, is expected to reach USD 141.85 billion by 2034, growing at a CAGR of 8.85% over the forecast period. The clinical trial services market is expanding due to growing outsourcing trends as well as rising patient-centric operations. North America led the market due to the presence of the largest sponsor base. 

  • Insight Code: 6031
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The clinical trial services market stands at USD 66.07 billion in 2025 and is expected to reach USD 141.85 billion by 2034, growing at a CAGR of 8.85% from 2024 to 2034.

North America is currently leading the clinical trial services market due to the presence of the largest sponsor base.

Some key players include IQVIA, Thermo Fisher Scientific, ICON plc, and Parexel. 

Key trends include rising investments for enhancing the clinical trial services using AI capabilities and growing collaboration to provide financing solutions to the clinical trials.

The clinical trial services are end-to-end outsourced and functional services that enable the design, setup, execution, and close-out of human clinical studies.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.